BioPharm News

Jul 25, 2016
By BioPharm International Editors
The companies will test the efficacy of Rova-T in combination with Opdivo, and Opdivo + Yervoy as a treatment for extensive-stage small cell lung cancer.
Jul 25, 2016
The vaccine candidate has also won a Priority Medicines (PRIME) status from EMA.
Jul 25, 2016
By BioPharm International Editors
The companies filed a BLA for romosozumab, an investigational monoclonal antibody for the treatment of osteoporosis.
Jul 22, 2016
By BioPharm International Editors
Curida will manufacture PCI Biotech’s Amphinex, a drug used to treat bile duct cancer.
Jul 22, 2016
By BioPharm International Editors
The conference will return to the COEX center in Seoul for the third year from August 23¬–25, 2016.
Jul 22, 2016
By BioPharm International Editors
Zenith appointed Carlos Machado as serialization director to lead the company’s sales, operations, and post project support services.
Jul 22, 2016
By BioPharm International Editors
The company opened a new service center in San Juan, Puerto Rico.
Jul 22, 2016
By BioPharm International Editors
The agency recommends suspending drugs developed with bioequivalence studies performed at Semler Research Centre Private Ltd, Bangalore, India.
Jul 22, 2016
By BioPharm International Editors
The company manufactures biological drug products and intermediates for the allergy vaccine market.
Jul 22, 2016
By BioPharm International Editors
The agency will review Mylan and Biocon’s biosimilar to pegfilgrastim.
lorem ipsum